» Articles » PMID: 33029101

Positive Association Between Metabolic Syndrome and Bone Mineral Density Among Malaysians

Overview
Journal Int J Med Sci
Specialty General Medicine
Date 2020 Oct 8
PMID 33029101
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Metabolic syndrome (MetS) is a cluster of metabolic abnormalities that elevates the individual risk of cardiovascular diseases. These abnormalities are also known to alter bone remodelling. Therefore, MetS may be associated with osteoporosis. This study aims to determine the association between MetS and its components and bone mineral density (BMD) assessed by dual-energy X-ray absorptiometry (DXA) among Malaysians. 400 Malaysians aged ≥ 40 years (52.5% women) residing in Klang Valley, Malaysia, were recruited. Subjects' demographic and lifestyle details were collected using a questionnaire, and blood pressure and body anthropometry were measured. Subjects' lumbar spine and total hip BMD were measured by DXA. Their fasting blood was collected for blood glucose level and lipid profile analysis. Regression analysis was used to analyze the relationship between MetS or its components and BMD. Subjects with MetS had higher BMD compared to subjects without MetS in models unadjusted for BMI (spine 0.008; hip 0.001). This difference was attenuated with BMI adjustment (spine 0.625; hip 0.478). Waist circumference was associated positively with BMD in models unadjusted for BMI (spine 0.012; hip 0.001), but the association became negative with BMI adjustment (spine 0.044; hip 0.021). Systolic blood pressure was associated positively with total hip BMD (0.019) but BMI adjustment attenuated the relationship (0.080). Triglyceride level was associated with osteoporosis in a fully adjusted model (0.001). Overall, MetS was associated with osteoporosis (0.019) but lifestyle (0.188) and BMI adjustment attenuated the relationship (0.904). MetS is positively associated with BMD, and this relationship is predominantly mediated by BMI. Although MetS is not a significant risk factor for osteoporosis, the inverse relationship between waist circumference, a marker of central obesity, and BMD highlights the need to prevent adiposity to improve metabolic and skeletal health.

Citing Articles

Fracture Risk Assessment in Metabolic Syndrome in Terms of Secondary Osteoporosis Potential. A Narrative Review.

Armutcu F, McCloskey E Calcif Tissue Int. 2025; 116(1):41.

PMID: 39979438 PMC: 11842537. DOI: 10.1007/s00223-025-01341-5.


The association of lipids and novel non-statin lipid-lowering drug target with osteoporosis: evidence from genetic correlations and Mendelian randomization.

Zheng Q, Lin R, Wang D, Chen R, Xu W BMC Musculoskelet Disord. 2025; 26(1):107.

PMID: 39893413 PMC: 11787747. DOI: 10.1186/s12891-024-08160-z.


The Effect of Statin Therapy on Bone Metabolism Markers and Mineral Density: Aa GRADE-Assessed Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials.

Arabi S, Chambari M, Bahrami L, Jafari A, Bahari H, Reiner Z Adv Pharm Bull. 2024; 14(3):591-603.

PMID: 39494267 PMC: 11530883. DOI: 10.34172/apb.2024.051.


The Role of Glucose, Insulin and Body Fat in Assessment of Bone Mineral Density and Trabecular Bone Score in Women with Functional Hypothalamic Amenorrhea.

Sowinska-Przepiera E, Krzyscin M, Syrenicz I, Orlinska A, Cwiertnia A, Przepiera A J Clin Med. 2024; 13(15).

PMID: 39124655 PMC: 11312711. DOI: 10.3390/jcm13154388.


Relative Contribution of Metabolic Syndrome Components in Relation to Obesity and Insulin Resistance in Postmenopausal Osteoporosis.

Greere D, Grigorescu F, Manda D, Voicu G, Lautier C, Nitu I J Clin Med. 2024; 13(9).

PMID: 38731059 PMC: 11084230. DOI: 10.3390/jcm13092529.


References
1.
Jeon Y, Lee J, Kim S, Kim B, Kim S, Kim Y . Association between bone mineral density and metabolic syndrome in pre- and postmenopausal women. Endocr J. 2011; 58(2):87-93. DOI: 10.1507/endocrj.k10e-297. View

2.
Dawodu D, Patecki M, Dumler I, Haller H, Kiyan Y . oxLDL inhibits differentiation of mesenchymal stem cells into osteoblasts via the CD36 mediated suppression of Wnt signaling pathway. Mol Biol Rep. 2019; 46(3):3487-3496. DOI: 10.1007/s11033-019-04735-5. View

3.
Chu A, Moy F . Reliability and validity of the Malay International Physical Activity Questionnaire (IPAQ-M) among a Malay population in Malaysia. Asia Pac J Public Health. 2012; 27(2):NP2381-9. DOI: 10.1177/1010539512444120. View

4.
Wan Mohamud W, Ismail A, Sharifuddin A, Ismail I, Musa K, Abdul Kadir K . Prevalence of metabolic syndrome and its risk factors in adult Malaysians: results of a nationwide survey. Diabetes Res Clin Pract. 2010; 91(2):239-45. DOI: 10.1016/j.diabres.2010.11.025. View

5.
Hernandez J, Olmos J, Pariente E, Martinez J, Valero C, Garcia-Velasco P . Metabolic syndrome and bone metabolism: the Camargo Cohort study. Menopause. 2010; 17(5):955-61. DOI: 10.1097/gme.0b013e3181e39a15. View